These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Ivacaftor: the first therapy acting on the primary cause of cystic fibrosis. McPhail GL; Clancy JP Drugs Today (Barc); 2013 Apr; 49(4):253-60. PubMed ID: 23616952 [TBL] [Abstract][Full Text] [Related]
23. Porcine nasal epithelial cultures for studies of cystic fibrosis sinusitis. Dean N; Ranganath NK; Jones B; Zhang S; Skinner D; Rowe SM; Sorscher EJ; Woodworth BA Int Forum Allergy Rhinol; 2014 Jul; 4(7):565-70. PubMed ID: 24733748 [TBL] [Abstract][Full Text] [Related]
25. Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics. Kunzelmann K; Mall M Am J Respir Med; 2003; 2(4):299-309. PubMed ID: 14719996 [TBL] [Abstract][Full Text] [Related]
26. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. Wilschanski M; Yahav Y; Yaacov Y; Blau H; Bentur L; Rivlin J; Aviram M; Bdolah-Abram T; Bebok Z; Shushi L; Kerem B; Kerem E N Engl J Med; 2003 Oct; 349(15):1433-41. PubMed ID: 14534336 [TBL] [Abstract][Full Text] [Related]
27. Resveratrol ameliorates abnormalities of fluid and electrolyte secretion in a hypoxia-Induced model of acquired CFTR deficiency. Woodworth BA Laryngoscope; 2015 Oct; 125 Suppl 7(0 7):S1-S13. PubMed ID: 25946147 [TBL] [Abstract][Full Text] [Related]
28. Dynamic regulation of airway surface liquid pH by TMEM16A and SLC26A4 in cystic fibrosis nasal epithelia with rare mutations. Delpiano L; Rodenburg LW; Burke M; Nelson G; Amatngalim GD; Beekman JM; Gray MA Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2307551120. PubMed ID: 37967223 [TBL] [Abstract][Full Text] [Related]
29. Development, clinical utility, and place of ivacaftor in the treatment of cystic fibrosis. O'Reilly R; Elphick HE Drug Des Devel Ther; 2013; 7():929-37. PubMed ID: 24039402 [TBL] [Abstract][Full Text] [Related]
30. The effect of CFTR modulators on a cystic fibrosis patient presenting with recurrent pancreatitis in the absence of respiratory symptoms: a case report. Johns JD; Rowe SM BMC Gastroenterol; 2019 Jul; 19(1):123. PubMed ID: 31296159 [TBL] [Abstract][Full Text] [Related]
32. Inflammation as a Regulator of the Airway Surface Liquid pH in Cystic Fibrosis. Rehman T; Welsh MJ Cells; 2023 Apr; 12(8):. PubMed ID: 37190013 [TBL] [Abstract][Full Text] [Related]
33. Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis. Graeber SY; Dopfer C; Naehrlich L; Gyulumyan L; Scheuermann H; Hirtz S; Wege S; Mairbäurl H; Dorda M; Hyde R; Bagheri-Hanson A; Rueckes-Nilges C; Fischer S; Mall MA; Tümmler B Am J Respir Crit Care Med; 2018 Jun; 197(11):1433-1442. PubMed ID: 29327948 [TBL] [Abstract][Full Text] [Related]
34. CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium. Zhang L; Button B; Gabriel SE; Burkett S; Yan Y; Skiadopoulos MH; Dang YL; Vogel LN; McKay T; Mengos A; Boucher RC; Collins PL; Pickles RJ PLoS Biol; 2009 Jul; 7(7):e1000155. PubMed ID: 19621064 [TBL] [Abstract][Full Text] [Related]
35. Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two Graeber SY; Vitzthum C; Pallenberg ST; Naehrlich L; Stahl M; Rohrbach A; Drescher M; Minso R; Ringshausen FC; Rueckes-Nilges C; Klajda J; Berges J; Yu Y; Scheuermann H; Hirtz S; Sommerburg O; Dittrich AM; Tümmler B; Mall MA Am J Respir Crit Care Med; 2022 Mar; 205(5):540-549. PubMed ID: 34936849 [No Abstract] [Full Text] [Related]
36. CFTR rescue with VX-809 and VX-770 favors the repair of primary airway epithelial cell cultures from patients with class II mutations in the presence of Pseudomonas aeruginosa exoproducts. Adam D; Bilodeau C; Sognigbé L; Maillé É; Ruffin M; Brochiero E J Cyst Fibros; 2018 Nov; 17(6):705-714. PubMed ID: 29661510 [TBL] [Abstract][Full Text] [Related]
37. Extracellular zinc and ATP restore chloride secretion across cystic fibrosis airway epithelia by triggering calcium entry. Zsembery A; Fortenberry JA; Liang L; Bebok Z; Tucker TA; Boyce AT; Braunstein GM; Welty E; Bell PD; Sorscher EJ; Clancy JP; Schwiebert EM J Biol Chem; 2004 Mar; 279(11):10720-9. PubMed ID: 14701827 [TBL] [Abstract][Full Text] [Related]
38. Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis. Sermet-Gaudelus I; Clancy JP; Nichols DP; Nick JA; De Boeck K; Solomon GM; Mall MA; Bolognese J; Bouisset F; den Hollander W; Paquette-Lamontagne N; Tomkinson N; Henig N; Elborn JS; Rowe SM J Cyst Fibros; 2019 Jul; 18(4):536-542. PubMed ID: 30467074 [TBL] [Abstract][Full Text] [Related]
39. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Van Goor F; Hadida S; Grootenhuis PD; Burton B; Cao D; Neuberger T; Turnbull A; Singh A; Joubran J; Hazlewood A; Zhou J; McCartney J; Arumugam V; Decker C; Yang J; Young C; Olson ER; Wine JJ; Frizzell RA; Ashlock M; Negulescu P Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18825-30. PubMed ID: 19846789 [TBL] [Abstract][Full Text] [Related]